Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are Neurotoxic  by Lee, Youn-Bok et al.
Cell Reports
ReportHexanucleotide Repeats in ALS/FTD Form
Length-Dependent RNA Foci, Sequester RNA
Binding Proteins, and Are Neurotoxic
Youn-Bok Lee,1 Han-Jou Chen,1 Joa˜o N. Peres,2 Jorge Gomez-Deza,1 Jan Attig,5,6 Maja Stalekar,3 Claire Troakes,1
Agnes L. Nishimura,1 Emma L. Scotter,1 Caroline Vance,1 Yoshitsugu Adachi,4 Valentina Sardone,1,7 Jack W. Miller,1
Bradley N. Smith,1 Jean-Marc Gallo,1 Jernej Ule,6 Frank Hirth,4 Boris Rogelj,3 Corinne Houart,2 and Christopher E. Shaw1,*
1Department of Clinical Neuroscience, King’s College London, Institute of Psychiatry, London SE5 8AF, UK
2MRC Centre for Developmental Neurobiology, London SE1 1UL, UK
3Department of Biotechnology, Jozef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia
4Department of Neuroscience, King’s College London, Institute of Psychiatry, London SE5 8AF, UK
5Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK
6MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK
7Department of Public Health, Neuroscience, Experimental, and Forensic Medicine, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy
*Correspondence: christopher.shaw@kcl.ac.uk
http://dx.doi.org/10.1016/j.celrep.2013.10.049
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works
License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are
credited.SUMMARY
The GGGGCC (G4C2) intronic repeat expansion
within C9ORF72 is the most common genetic cause
of amyotrophic lateral sclerosis (ALS) and frontotem-
poral dementia (FTD). Intranuclear neuronal RNA
foci have been observed in ALS and FTD tissues,
suggesting that G4C2 RNA may be toxic. Here, we
demonstrate that the expression of 383 and 723
G4C2 repeats form intranuclear RNA foci that initiate
apoptotic cell death in neuronal cell lines and zebra-
fish embryos. The foci colocalize with a subset of
RNA binding proteins, including SF2, SC35, and
hnRNP-H in transfected cells. Only hnRNP-H binds
directly to G4C2 repeats following RNA immunopre-
cipitation, and only hnRNP-H colocalizeswith 70%of
G4C2 RNA foci detected in C9ORF72 mutant ALS
and FTD brain tissues. We show that expanded
G4C2 repeats are potently neurotoxic and bind
hnRNP-H and other RNA binding proteins. We pro-
pose that RNA toxicity and protein sequestration
may disrupt RNA processing and contribute to
neurodegeneration.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) causes progressive muscle
weakness and spasticity due to the degeneration of motor neu-
rons. Frontotemporal dementia (FTD) causes changes in person-
ality, language, and behavior due to the degeneration of neurons
in frontal and temporal lobes. Both are fatal within 3–5 years of
symptom onset. Multiple lines of evidence indicate that these
two disorders are phenotypic variants of common pathological1178 Cell Reports 5, 1178–1186, December 12, 2013 ª2013 The Autprocesses involving the deposition of TDP-43 (Neumann et al.,
2006) or FUS (Vance et al., 2009). A common basis for ALS
and FTD came from genetic linkage studies that identified a
locus on chromosome 9p21 in familial ALS-FTD (Vance et al.,
2006) and genome-wide association studies in sporadic ALS
and FTD (Shatunov et al., 2010). The underlying mutation was
subsequently shown to be an expansion of the GGGGCC
(G4C2) repeat within intron 1 of C9ORF72 (DeJesus-Hernandez
et al., 2011; Renton et al., 2011). This mutation accounts for
20%–80% of familial and 5%–15% of sporadic ALS and FTD
in North American and European populations (DeJesus-Hernan-
dez et al., 2011; Renton et al., 2011; Smith et al., 2012). The size
of the repeat in ALS and FTD cases has been estimated by
Southern blotting to range between 700 and 1,600 repeats
(DeJesus-Hernandez et al., 2011). The mean number of G4C2
repeats in controls is two; 95% have less than eight repeats
(Smith et al., 2012).
The mechanism by which the G4C2 intronic repeats cause
neurodegeneration is unknown. Decreased tissue levels of the
C9ORF72 transcript implicate a loss of protein function due to
haploinsufficiency (DeJesus-Hernandez et al., 2011; Renton
et al., 2011). Recent reports describe the aggregation of pep-
tides due to repeat-associated non-ATG (RAN) translation
(Mori et al., 2013b) as previously described in SCA8 (Zu et al.,
2011). Antibodies against poly (Gly-Ala), (Gly-Pro), and (Gly-
Arg) peptides selectively label p62-positive, TDP-43-negative
neuronal inclusions that are the pathological hallmark of mutant
C9ORF72 cases (Al-Sarraj et al., 2011), but evidence that pep-
tide aggregation initiates neurodegeneration is currently lacking.
The identification of intranuclear neuronal RNA foci containing
G4C2 repeats in ALS and FTD tissues (DeJesus-Hernandez
et al., 2011) is similar to other intronic repeat expansion disor-
ders, including myotonic dystrophy, fragile X tremor ataxia syn-
drome, and several spinocerebellar ataxias (Todd and Paulson,
2010). RNA foci in myotonic dystrophy sequester and depletehors
Figure 1. Expanded G4C2 Repeats Form
Intranuclear RNA Foci
(A–D) SH-SY5Y cells were transfected with various
length G4C2 (0, 8, 38, 72 repeat) plasmids and
analyzed 24 hr after transfection by RNA FISH
using a Cy3-labeled (G2C4)38 RNA probe.
(E) The mean number of G4C2 foci was counted in
50 cells.
(F–I) Primary hippocampal mouse neurons (F),
CV1 (G), HEK293 (H), and HeLa (I) cells were
transfected with a plasmid expressing G4C2 723
repeats; foci were detected by FISH (red) and
nuclei were stained with DAPI (blue). All cell types
transfected with 383 and 723 repeats showed
foci (scale bar represents 3 mm).
See also Figure S1.muscle-blind-like protein (MBNL1), ultimately causing wide-
spread RNA splicing abnormalities and degeneration of affected
tissues (Miller et al., 2000). The fact that overexpression of
MBNL1 can rescue the phenotype caused by the CTG repeats
implies that loss of MBNL1 is one of the key drivers of cellular
degeneration (Kanadia et al., 2003a).
In order to determine whether expanded G4C2 transcripts
might be toxic and sequester RNA binding proteins, we gener-
ated G4C2 with 83, 383, and 723 repeats and expressed
them in cell lines, primary neurons, and zebrafish embryos.
Here, we demonstrate that the longer repeat lengths generate
RNA foci that are toxic to neurons and bind the RNA binding pro-
teins SF2, SC35, and hnRNP-H. hnRNP-H directly binds toG4C2
RNA and colocalizes closely with RNA foci in transfected cells
and the brains of human C9ORF72 ALS and FTD cases. Our
findings indicate that G4C2 repeat expansions are potently toxic,
sequester RNA proteins, and may initiate neurodegeneration in
mutant C9ORF72 ALS and FTD.
RESULTS
Using direct ligation we generated constructs containing 83, 38
3, and 723 G4C2 repeats, which were cloned into an untagged
plasmid vector (Figures S1A–S1D). Following transfection into
neuronal (SH-SY5Y) cell lines, intranuclear G4C2-positive RNA
foci were detected by RNA fluorescence in situ hybridization
(FISH) in all cell types expressing 383 and 723 repeats, but
not in cells expressing 83 repeats (Figure 1A). Themean numberCell Reports 5, 1178–1186, Deof foci per cell was six for 383 repeats
and 12 for 723 repeats (Figure 1E). These
were expressed in a range of human
nonneuronal cells (CV1, HEK, HeLa) and
primary rat cortical neurons (Figures 1F–
1I). The RNA foci were resistant to RNase
and DNase treatments (Figures S1E and
S1F), consistent with the description of
G4C2 DNA repeat hairpin loops forming
G quadruplexes in vitro (Fratta et al.,
2012).
In order to determine whether the
length of the G4C2 repeat affected nucle-ocytoplasmic trafficking of the transcript, we cloned the 83, 383,
and 723 repeat constructs into the 30 position of EGFP expres-
sion vectors (Figure S2A). Equivalent transcript expression
was detected by RT-PCR and northern blotting for 83, 383,
and 723 repeat vectors (Figures S2B and S2C). Again, 383
and 723, but not 83, repeats or EGFP alone, generated G4C2
RNA foci in SH-SY5Y cell lines (Figures 2A–2D). After 24 hr we
observed that a significant proportion of cells with intranuclear
RNA foci expressed little or no EGFP (19% ± 1.9% for 383 and
23% ± 1.8% for 723 repeats) (Figure 2E). The absence of
EGFP in cells containing foci implies nuclear retention of mRNA
containing longer repeats and that foci form shortly after tran-
scription precluding nuclear export. In a time course experiment
we observed that the number of SH-SY5Y cells bearing RNA
foci decreased dramatically over 72 hr. This was most marked
in foci-positive cells that were EGFP negative, such that by
72 hr there was a >90% decrease in the number of cells showing
foci for 383 and 723 G4C2 repeats (Figure 2E). Cells with foci
that also expressed EGFP (demonstrating nuclear export and
cytoplasmic translation) showed a more modest decrease of
30% (EGFP-G4C2 383) and 21% (EGFP-G4C2 723), respec-
tively (Figure 2E’).
In order to determine whether this decline in numbers was due
to toxicity induced by RNA foci, we measured the expression of
the apoptosis marker Annexin V by fluorescence-activated cell
sorting (FACS). FACS analysis showed that the proportion of
EGFP-positive cells expressing Annexin V was 3-fold higher
for 383 repeats and 5-fold higher for 723 repeats comparedcember 12, 2013 ª2013 The Authors 1179
(legend on next page)
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to 83 repeats (Figure 2F). To investigate this further, immunocy-
tochemistry (ICC) for activated caspase-3 was performed; it
showed that in SH-SY5Y cells, RNA foci dramatically enhanced
the activation of caspase-3 (Figure 2G). To quantify the induction
of apoptosis by G4C2 foci, we counted caspase-3-activated
cells in both foci-negative and foci-positive cell populations.
We found no change in the proportion of caspase-3-activated
cells above background (3.2% ± 1.2%) in SH-SY5Y cells ex-
pressing 83 repeats but a dramatic increase in cells with foci
from 383 (37% ± 2.7%) and 723 (34% ± 6.9%) repeats
(Figure 2H). Interestingly, HEK293 cells expressing G4C2 383
or 723 showed no evidence of apoptosis despite abundant
G4C2 foci (Figure 2H). Accordingly, poly(ADP-ribose) polymer-
ase (PARP) cleavage was detected in 383 or 723 repeat
transfected SH-SY5Y cells, but not in HEK293 cells (Figure 2I),
suggesting that neuronal cells may be more vulnerable to
apoptotic cell death triggered by G4C2 RNA foci.
We next sought to test for length-dependent G4C2
toxicity in vivo by injecting the EGFP constructs with 83, 383,
and 723 repeats into zebrafish embryos. DNA injection leads
to mosaic distribution of the DNA and expression in only a small
portion of the embryonic cells. Embryos were injected at the
one-cell stage and analyzed at prim-5 (approximately 24 hr post-
fertilization). Expression of the EGFP-G4C2 83 repeat did not in-
crease the number of apoptotic cells above EGFP alone (Figures
2J and 2K); however, injection of the 383 or 723 G4C2 repeat
constructs (Figures 2L and 2M) resulted in a significant increase
in TUNEL-positive cells of 0.8- and 1.4-fold, respectively (graph-
ically represented in Figure 2N). G4C2-positive RNA foci
detected by FISH were only observed in 723 embryos, but not
in 83 embryos (Figures 2O and 2O’). The majority of 723-trans-
fected cells that had G4C2-positive RNA foci were also active
caspase-3 positive (Figure S2D). TUNEL and active caspase-3-
positive cells showed nuclear condensation and fragmentation
confirming apoptotic cell death (Figures 2P and 2Q). Thus, evi-
dence from cellular and in vivo assays indicates that longerFigure 2. Loss of G4C2 Foci-Positive Cells Is Due to Apoptotic Cell De
(A–D) SH-SY5Y cells were transfected with EGFP-tagged G4C2 constructs. G4C
EGFP-G4C2 723 repeats. Many cells with RNA foci were negative for EGFP (arro
with DAPI (blue) (scale bar represents 10 mm).
(E) The percentage of cells with G4C2 foci by FISH that did not express EGFP we
that did express EGFP (E’). Foci-positive cells declined in number, mostmarkedly
250 cells from three independent transfections were counted, and results are pr
(F) EGFP-tagged G4C2 plasmids were transfected into SH-SY5Y cells, staine
expressing 383 and 723 repeats showed 3- or 5-fold higher levels of Annexin V
(G) G4C2 foci-positive SH-SY5Y cells were found positive for activated caspase
(H) G4C2 RNA foci-positive SH-SY5Y cells, but not HEK293 cells, express activa
coverslip, and three coverslips were analyzed per experiment. The background
caspase-3-positive cells in the foci-negative population.
(I) Western blot of PARP cleavage in control or G4C2-transfected SH-SY5Y and
(J–M) Apoptotic cell death was analyzed by TUNEL staining in zebrafish prim-5 em
(K), EGFP-G4C2 383 (L), or EGFP-G4C2 723 (M). The number of TUNEL-positive
M) (scale bar represents 200 mm).
(N) Quantification of all embryos (n = 5) from three independent experiments is
(p < 0.0001, ***) are also determined.
(O) G4C2 RNA foci (red) were found only in zebrafish embryo cells injected with
(P and Q) High-resolution images of TUNEL-positive (P and P0) and active cas
represents 10 mm). Nuclear staining is blue.
See also Figure S2.
Cell ReG4C2 repeats lead to the nuclear retention of transcripts, form-
ing RNA foci that are RNase resistant and potently toxic.
To investigate whether RNA processing proteins were bound
to the G4C2 RNA foci, we probed transfected SH-SY5Y cells
with antibodies to 30 different RNA-binding proteins based on
their known or predicted ability to bind GC-rich sequences,
including heterogeneous nuclear proteins (hnRNP) and serine-
arginine (SR) proteins involved in splicing and trafficking (Tables
S1 and S2). We found that antibodies to three proteins colocal-
ized with the G4C2 RNA foci: hnRNP-H, serine-arginine-rich
splicing factor 1 (SF2), and serine-arginine-rich splicing factor
2 (SC35). hnRNP-H showed the closest association with the
foci with almost complete overlap, compared to the distribution
of SF2 and SC35 (Figures 3A and 3B). TDP-43 was not mislocal-
ized in any cells with RNA foci. To determine whether these
proteins are physically binding to G4C2 RNA, we extracted nu-
clear lysate from SH-SY5Y cells, incubated it with biotin-labeled
G4C2372 RNA, and performed RNA immunoprecipitation (RIP).
Western blots of the eluate were probed for all three proteins, but
only hnRNP-H was detected (Figure 3C). To further validate the
interaction between G4C2 repeats and hnRNP-H, we performed
RIP using rat brain nuclear lysate. hnRNP-H was pulled down
from rat brain lysate by G4C2348 RNA, but not by control
RNA of the same length (300 nt), implying that hnRNP-H binds
specifically to G4C2 repeats (Figure 3D). Sequestration of
hnRNP H by G4C2 RNA foci is expected to reduce the amount
of hnRNP-H available and reduce its splicing efficiency on spe-
cific RNA targets. hnRNP-H is required for the efficient inclusion
of exon 7 into the mature TARBP2 RNA (Xiao et al., 2009). We
therefore compared the effect of expanded G4C2 repeats and
knockdown of hnRNP-H on TARBP2 exon 7 inclusion. Lentiviral
constructs expressing sh-hnRNP-H knocked down hnRNP-H
with an efficiency of 95% in SH-SY5Y cells (Figure S3), which
dramatically decreased the inclusion of exon 7 into TARBP2 (Fig-
ure 3E). A more modest decrease in exon 7 inclusion was also
observed in SH-SY5Y cells stably transfected with 723 G4C2ath in Culture and In Vivo
2 RNA foci (red) were found only in cells transfected with EGFP-G4C2 383 and
ws in C and D), implying near-complete nuclear retention. Nuclei were stained
re counted at 24, 48, and 72 hr posttransfection (E), as were foci-positive cells
in those showing greater nuclear retention (EGFP). In all experiments, a total of
esented as mean ± SD.
d with the early apoptosis marker Annexin V, and analyzed by FACS. Cells
, respectively, than did cells expressing 83 repeats.
-3 (scale bar represents 5 mm).
ted caspase-3. Caspase-3 activation was scored in 250 foci-positive cells per
level of active caspase-3 was estimated by counting the frequency of active
HEK293 cells. Actin was used as a loading control.
bryos injected with plasmids mosaically expressing EGFP (J), EGFP-G4C2 83
cells (red) increased in the embryos injected with 383 and 723 repeats (L and
presented. Error bars show the standard error for each sample, and p values
723, but not with 83 repeats. EGFP expression is green.
pse-3 (Q and Q0) from zebrafish embryo cells injected with 723 (scale bar
ports 5, 1178–1186, December 12, 2013 ª2013 The Authors 1181
(legend on next page)
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plasmids (Figure 3F). Thus, the presence of G4C2 repeats has a
similar effect on the splicing of TARBP2 exon 7 to hnRNP-H
knockdown and is consistent with the effect of hnRNP-H
sequestration by G4C2 foci.
Having determined that three RNA binding proteins colocalize
with G4C2 RNA foci in cells, we sought a similar association in
human tissues. We optimized our FISH protocol (adapted from
DeJesus-Hernandez et al. [2011]) and observed abundant RNA
foci in the cerebellum and less abundant foci in the frontal cortex
and temporal lobes of ALS and FTD patients carrying the
C9ORF72 expansion mutation (confirmed by repeat primed
PCR and Southern blot, n = 5) that are absent from controls
(n = 5) (Figure S4; Table S3). Discrete intranuclear neuronal
RNA foci were larger in the cerebellum (500 nm) compared to
the cortex (200nm) andweremost frequent in neurons adjacent
to Purkinje cells (Figures 4A and 4B). By combining FISH for RNA
foci and immunofluoresence for the foci-associated RNAbinding
proteins identified in transfected cells, wedemonstrated that SF2
andSC35 rarely colocalizedwithG4C2RNA in cerebellum, being
present in <5%of foci, whereas hnRNP-H showed striking coloc-
alization overlapping almost with 70% of foci (Figures 4C–4F).
We have therefore confirmed the presence of RNA foci in ALS
and FTD patients with pathological G4C2 intronic expansions in
C9ORF72 and demonstrated that they bind RNA-binding pro-
teins, being most closely associated with hnRNP-H.
DISCUSSION
The G4C2 expansion mutation in C9ORF72 is the most common
gene defect associated with ALS and FTD in the European pop-
ulation. Several mechanistic hypotheses are emerging, including
the loss of the C9ORF72 encoded protein, RNA-mediated
toxicity (DeJesus-Hernandez et al., 2011; Renton et al., 2011),
and toxic dipeptides from repeat-associated non-ATG (RAN)
translation (Mori et al., 2013b). Our results provide experimental
evidence that RNA containing longer G4C2 repeats causes
cellular toxicity in a length-dependent manner in transfected
cells and in vivo and may contribute to neurodegeneration in
C9ORF72-related ALS and FTD.
Cellular toxicity was associated with the nuclear retention of
transcripts containing 383 and 723 repeats and the appearanceFigure 3. SC35, SF2, and hnRNP-H Colocalize with G4C2 Nuclear Foci
(A–B) SH-SY5Y cells were transfected with a plasmid expressing 723 repeats an
(ICC). (A andB) Endogenous SC35 (A) and SF2 (B) were detected by ICC using aD
by ICC, using a Dylight-649-labeled secondary antibody. The intensity of endoge
tools (scale bar represents 5 mm).
(C) Biotin-labeled G4C2372 RNA transcripts were synthesized and used for RN
Partial colocalization of SC35 and SF2 is seen with the RNA foci, whereas hnRNP
72 RNA.
(D) Biotin aptamer-labeled G4C2348 RNA transcripts were synthesized and u
cedures); RNA of equivalent length to G4C2348 (300 nt) was used as a control.
(E) Splicing assay of TARBP2 exon 7 shows that G4C2RNA sequestration of hnRN
SH-SY5Y cells validates that hnRNP H promotes inclusion of TARBP2 exon 7.
(F) Analysis of TARBP2 exon 7 splicing in SH-SY5Y cells stably transfected with C
G4C2372 but is not affected in cells expressing lower repeat numbers. PCR prod
the right. Average quantification values of exon inclusion (yellow) and exclusion (b
ratio between exon 7 inclusion and exclusion was calculated and tested by one-
See also Figure S3.
Cell Reof RNA foci. By placing the repeats 30 to EGFP we were able to
monitor nuclear export and show that transfected neuroblas-
toma cells, but not HEK cells, declined in number over time
because of apoptotic cell death. This was most marked in those
showing the greatest nuclear retention and foci, indicating cell
type and neuron-specific toxicity of longer G4C2 repeats. These
data suggest that similar to trinucleotide diseases (Hirth, 2010),
cellular toxicity of hexanucleotide repeat expansion directly cor-
relates with G4C2 repeat length, indicating that the longer the
repeat, the more toxic its nature.
In order to explore the sequestration hypothesis, we screened
antibodies to 30 RNA binding proteins in G4C2 723-transfected
neuroblastoma cells and demonstrated colocalization of G4C2
RNA foci with SF2, SC35, and, most strikingly, hnRNP-H. Over-
expression of 723 G4C2 and knockdown of hnRNP-H had a
similar effect on the splicing of a target RNA TARBP2, consistent
with the sequestration of hnRNP-H. Using biotinylated 723RNA,
we were only able to pull down hnRNP-H, indicating that is able
to interact with G4C2 RNA. On probing human cerebellar ALS
and FTD tissues, we detected a striking colocalization of
hnRNP-H with 70% of RNA foci. We did not detect changes in
the distribution or colocalization with RNA foci in human tissues
for pur-a (Xu et al., 2013) or hnRNP-A3 (Mori et al., 2013a) to sug-
gest sequestration, as had previously been postulated. Our find-
ings suggest that the sequestration of hnRNP-H and other RNA
binding proteins may play a mechanistic role in neurodegenera-
tion associated with the C9ORF72 mutation.
Our observation that longer stretches of G4C2 RNA form
neurotoxic foci and bind specific RNA binding proteins is similar
to other intronic microsatellite expansion disorders (Todd and
Paulson, 2010). Expanded CUG (DM1) and CCUG (DM2) in-
tronic repeats generate RNA foci in cells, in animal models,
and in patients with myotonic dystrophy. The foci bind and
deplete muscle-blind-like proteins (MBNL1, 2, and 3), causing
widespread RNA splicing abnormalities and degeneration of
affected tissues (Miller et al., 2000). The fact that MBNL1
knockout mice develop key aspects of human DM and that
overexpression of MBNL1 in Drosophila and mice can rescue
the phenotype caused by the CTG repeats implies that loss of
MBNL1 is one of the key drivers of cellular degeneration (Kana-
dia et al., 2003b)., but hnRNP-H Binds to G4C2 RNA Transcripts
d probed 24 hr after transfection for G4C2 by FISH and immunocytochemistry
ylight-488-labeled secondary antibody. hnRNP-Hwas simultaneously detected
nous SC35, SF2, hnRNP-H, and G4C2 foci were analyzed by Leica line profile
A pull-down of SH-SH5Y lysates; G4C230 transcripts were used as control.
-H shows very close colocalization. Only hnRNP-H coprecipitated with G4C23
sed for RNA pull-down of rat brain lysates (Supplemental Experimental Pro-
hnRNP-H coprecipitated with G4C2348 RNA.
P-H impairs RNA processing. Comparison of hnRNPH knockdown and control
9ORF72 repeats. Inclusion of TARBP2 exon 7 is decreased in cells expressing
ucts including (in) or excluding (ex) the regulated alternative exon aremarked on
lue) are shown. Error bars show SD of three replicates. To test significance, the
way ANOVA and Tukey’s honestly significant difference test.
ports 5, 1178–1186, December 12, 2013 ª2013 The Authors 1183
Figure 4. Intranuclear Neuronal RNA Foci in C9ORF72 Mutant ALS and FTD Brain Tissues Colocalize Very Closely with hnRNP-H
(A) Image of mutant C9ORF72 patient cerebellum overlaid with the location of neurons containing G4C2 RNA foci (red dots) (scale bar represents 4 mm).
(B) G4C2 RNA foci-positive neurons (white arrow) were observed between the granular and molecular layer of the cerebellum (scale bar represents 10 mm).
(C–E) FISH and ICCwere performed for hnRNP-H (C), SC35 (D), and SF2 (E), with aG4C2mutation-negative ALS case used as control (scale bar represents 3 mm).
(F) The percentage of foci that colocalized with hnRNP-H, SF2, and SC-35were counted (n = 50 cells). Of the three RNA binding proteins that colocalized with foci
in transfected cells, only hnRNP-H shows a striking degree of overlap for 70% of all foci in the cerebellum.
See also Figure S4.hnRNP-H binds strongly to G-runs in intronic sequences to
enhance exon skipping (Xiao et al., 2009) and G-rich RNA quad-
ruplexes (Millevoi et al., 2012). hnRNP-H binding is known to
inhibit the nuclear export of RNA containing expanded CUG re-
peats associated with myotonic dystrophy type 1 (DM1) (Kim
et al., 2005). It is a component of the splicing enhancer complex
that activates alternative splicing of c-src in neurons (Chou et al.,
1999). Thus, the nuclear retention and aggregation of G4C2 RNA
may be enhanced by hnRNP-H binding, which could in turn facil-
itate further G4C2 RNA binding in a positive feedback loop to
generate large RNase-resistant foci. This would result in the
sequestration of hnRNP-H itself, other RNA binding proteins,
andmultiple RNA transcripts, leading to significant dysregulation
of RNA processing and toxicity. We did not observe TDP-43
binding to G4C2 repeats or mislocalization in our cellular models
as has been described in C9ORF72mutant ALS and FTD cases,1184 Cell Reports 5, 1178–1186, December 12, 2013 ª2013 The Autand it is not yet clear whether TDP-43 misaccumulation is mech-
anistic in these cases. The observation that RAN translation gen-
erates dipeptides in C9ORF72 mutant cases is of great interest
(Mori et al., 2013b). Recent evidence has emerged that RAN pol-
yglycine peptides are present in cellular and Drosophila models
of fragile X tremor ataxia syndrome and in patients carrying the
CGG expansion and that cell death could be prevented by the
suppression of RAN translation (Todd et al., 2013). Toxicity due
to RNA foci and RAN translation are not mutually exclusive,
and their relative contribution to repeat-associated neurodegen-
erative disorders requires further investigation.EXPERIMENTAL PROCEDURES
Detailed Experimental Procedures are described in the Supplemental Experi-
mental Procedures.hors
Patient Samples
All cases were provided by the Medical Research Council (MRC) London
NeurodegenerativeDiseasesBrainBank (Institute of Psychiatry, King’sCollege
London) and were collected and distributed in accordance with local and
national research ethics committee approvals. See Table S3 for case details.
FISH with Immunofluoroscence
Cy3-labeledG2C438 RNA probes were synthesized by Integrated DNA Tech-
nologies and used as antisense probes. Cells were fixed in 4% PFA for 15 min
and washed with PBS. Then cells were incubated with 70% ethanol overnight
(16 hr) at 4C. The next day, the cells were rehydrated in PBS for 15 min and
permeabilized with 0.1% Triton X-100 for 5 min. Following this, the coverslips
were incubated in prehybridization solution (40% formamide, 23SSC) for
15 min. Probes were used at working solutions of 5 ng/ml and diluted in
hybridization buffer (40% formamide, 1 mg/ml tRNA, 10% dextran sulfate,
23SSC). Following overnight hybridization at 48C, coverslips were washed
three times in 2X SSC at room temperature for 15 min each. These were then
washed with PBS three times for 15 min each. Coverslips were treated with
RNase A/T1 mix (Fermentas, 1:50,000) for 5 min at room temperature and
washed with PBS three times for 15 min each. For double immunostaining
with FISH, coverslips were blocked in 5%donkey serum for 1 hr, and then cells
were incubated with primary antibodies (Table S2), and the appropriate sec-
ondary antibodies were used. DAPI (Sigma) was used for counterstaining. Le-
ica confocal SP systems were used for high-resolution imaging.
FISH for Human Tissue
Sections from frontal and temporal cortices and cerebellum were provided as
10% formalin fixed and paraffin-embedded blocks. To perform FISH, paraffin
was removed with xylene, and sections were rehydrated in an ethanol series
(100%, 95%, 70%) for 3 min per step. These slides were incubated in 0.3%
Sudanblack for5minandwashedwithwater.Next, slideswere treatedwithpro-
teinase-K (20 mg/ml, TBS [pH 7.4]) in a 37C water bath for 20 min. Next, slides
were treated with ice-cold 20% acetic acid in 13 TBS for 2 min and then incu-
bated in prehybridization buffer (40% formamide, 23SSC) for a further
15 min. Probes were used at working solutions of 5 ng/ml and diluted in hybrid-
ization buffer (403 formamide, 1 mg/ml tRNA, 10% dextran sulfate, 23SSC).
Following overnight hybridization at 48C, slides were washed three times in
2X SSC at room temperature for 15 min each. These were then washed with
PBS three times for 15 min each.
Statistics
Statistical analysis was carried out using GraphPad Prism 5. For one-way
ANOVA, Bonferroni post hoc tests were used to compare the abundance of
TUNEL-stained cells in zebrafish. Data are presented as mean ± SEM. Statis-
tical significance was considered at p < 0.0001 (***).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2013.10.049.
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